Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom
    Guideline Concordant Care and New Data for Patients with MIBC through la/mUC
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom
    Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophilia
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom
    Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease Registry
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Germany
    Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia Infections
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Advancing Multidisciplinary Care in Hemophilia
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    INNOVAtive Multi-disciplinary Clinical Management of INflammatory Diseases, 2023 IT INNOVA-MIND
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Italy
    Quality Improvement in Pediatric Endocrinology Fields
    Release Date:
    Partner: The Japanese Society for Pediatric Endocrinology
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease Japan
    Biomarker Testing / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Employment Support / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    2023 Oncology Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Fellowship Oncology Canada
    Approaches to Implement Bispecific Antibodies into Clinical Practice, Increase Awareness and Improve Delivery of Quality of Care
    Release Date:
    Partner: Myeloma Canada
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Improving Health Equity via Clinical Trial Capability Development in China
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions China
    Combination Therapy with Relugolix in the Treatment of Advanced Prostate Cancer
    Release Date:
    Partner: National Comprehensive Cancer Network; Myovant Sciences
    Review Process: Expert Review Panel
    Research Oncology USA
    Optimizing Women’s Health Conditions in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Internal Medicine Canada
    Women’s Health
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Internal Medicine Canada
    Accelerating Advancements in Women’s Health
    Release Date:
    Partner: Myovant Sciences
    Review Process: Expert Review Panel
    Research Internal Medicine USA
    Implementing Rapid Turnaround Time for NGS Molecular Testing for Cancer Patients in Non-Academic and Community Centres
    Release Date:
    Partner: Colorectal Cancer Canada and Thermo Fisher Scientific
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada